Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | HLA-DOA |
| Upstream (Parents) |
|---|
| (<<) ACTN3 → HLA-DOA |
| (<<) ADAM12 → HLA-DOA |
| (<<) COIL → HLA-DOA |
| (<<) CRCT1 → HLA-DOA |
| (<<) IL1R2 → HLA-DOA |
| (<<) PDGFB → HLA-DOA |
| (<<) PIP4K2A → HLA-DOA |
| (<<) PITPNA → HLA-DOA |
| (<<) PRKCB → HLA-DOA |
| (<<) PRSS3 → HLA-DOA |
| (<<) PTGER1 → HLA-DOA |
| (<<) SHC1 → HLA-DOA |
| (<<) SOCS3 → HLA-DOA |
| (<<) SPRR1B → HLA-DOA |
| Downstream (Children) |
|---|
| HLA-DOA → BPGM (>>) |
| HLA-DOA → CEBPE (>>) |
| HLA-DOA → DRD4 (>>) |
| HLA-DOA → IL1F9 (>>) |
| HLA-DOA → IL1RN (>>) |
| HLA-DOA → KLK7 (>>) |
| HLA-DOA → MMP17 (>>) |
| HLA-DOA → PDK2 (>>) |
| HLA-DOA → RPA4 (>>) |
